Cullinan Management Receives ‘Buy’ Rating as Phase 2b Study Success and Taiho Partnership Boost Prospects
Edward White, an analyst from H.C. Wainwright, reiterated the Buy rating on Cullinan Management (CGEM – Research Report). The associated price ...
Positive Buy Rating for Cullinan Management Driven by Zipalertinib’s Promising Efficacy and Strategic Partnership with Taiho Oncology
JonesTrading analyst Soumit Roy maintained a Buy rating on Cullinan Management (CGEM – Research Report) today and set a price target of ...